DiscoverThe Lancet in conversation withPrasad Kulkarni on a vaccine against typhoid and paratyphoid
Prasad Kulkarni on a vaccine against typhoid and paratyphoid

Prasad Kulkarni on a vaccine against typhoid and paratyphoid

Update: 2024-05-02
Share

Description

Prasad Kulkarni joins Callam Davidson of The Lancet to discuss the safety and immunogenicity of a bivalent conjugate vaccine against typhoid and paratyphoid, following the publication of a phase 1 trial.

Read the full article:
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(24)00249-6/fulltext?dgcid=buzzsprout_icw_podcast_generic_lancet

Continue this conversation on social!
Follow us today at...
https://thelancet.bsky.social/
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv

Comments 
In Channel
ASCO 2025 Debrief

ASCO 2025 Debrief

2025-06-1115:14

Previewing ASCO 2025

Previewing ASCO 2025

2025-05-3005:24

loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Prasad Kulkarni on a vaccine against typhoid and paratyphoid

Prasad Kulkarni on a vaccine against typhoid and paratyphoid

The Lancet Group